Summary
The current biopharmaceutical applications of stable isotopes are reviewed. The advantages and drawbacks of the techniques based upon these isotopes are also discussed in comparison with those related to radioisotopes.
Similar content being viewed by others
References
Caprioli, R. M., 1972,in: « Biochemical applications of mass spectrometry », G. R. Waller Ed., Wiley-Interscience.
Fales, H. M., Milne, W. A., Winkler, H. U., Beckey, H. D., Damico, J. N. and Barrow, R., 1975, Anal. Chem., Comparison of mass spectra of some biologically important compounds as obtained by various ionization techniques,47, 207–219.
Reed, R. I., 1971, « Recent topics in mass spectrometry», Gordon and Breach Science Publishers, N. Y.
Gordon, A. E. and Frigerio, A., 1972, J. Chromatogr., Mass fragmentography as an application of gas liquid chromatography-mass spectrometry in biological research,73, 401–417.
Henneberg, D., 1959, Z. Anal. Chem., Ein Kontinuierliches Verfahren zur massenspektrometrische Bestimmung gas-chromatographisch vorgetrennter substanzgemische,170, 365–366.
Henneberg, D., 1961, Z. Anal. Chem., Combination of gas chromatography and mass spectrometry for the analysis of organic mixtures,183, 12–23.
Encyclopaedia Britannica, 1974, Macropaedia,11, 604.
Urey, H. C, Brickwedde, F. G. and Murphy, G. M., 1932, Phys. Rev., A hydrogen isotope of mass 2,39, 164–165.
Schoenheimer, R. and Rittenberg, D., 1935, J. Biol. Chem., Deuterium as an indicator in the study of intermediary metabolism,111, 163–192.
Harrow, B. and Mazur, A., 1966, «Textbook of biochemistry», Saunders Co., Philadelphia-London.
Rittenberg, D. and Waelsch, H., 1940, J. Biol. Chem., The source of carbon for urea formation,136, 799–800.
Knapp, D. R. and Gaffney, T. E., 1972, Clin. Pharmacol. Ther., Use of stable isotopes in pharmacology,13 (3), 307–316.
Sweeley, C. C, Elliott, W. H., Fries, I. and Ryhage, A., 1966, Anal. Chem., Mass spectrometric determination of unresolved components in gas chromatographic effluents,38, 1549–1553.
Strolin-Benedetti, M. and Strolin, P., 1973, Pharmacologie Clinique, The use of stable isotopes in metabolic studies,1, 15–23.
Thomas, A. F., 1971, «Deuterium labeling in organic chemistry», Meredith Corporation, Appleton, N. Y.
Mrtek, R. G. Crespi, H. L., Blake, M. I. and Katz, J. J., 1965, J. Pharm. Sci., Effect of deuterium oxide on the saprophytic culture of claviceps I,54, 1450–1453.
Blake, M. I., Crespi, H. L. and Katz, J. J., 1975, J. Pharm. Sci., Studies with deuterated drugs,64, 367–391.
Vree, T. B., Gorgels, J. P. M. C, Muskens, A. T. J. M. and Van Rossum, J. M., 1971, Clin. Chim. acta, Deuterium isotope effects in the metabolism of N-alkyl-substituted-amphetamines in man,34, 333–344.
Castagnoli, N. Jr, Dagne, E. and Gruenke, L. D., 1974, in: «Mass spectrometry in biochemistry and medicine», Ed. A. Frigerio and N. Castagnoli, Raven Press, N. Y.
Thompson, J. F., 1973, «Biological effects of deuterium», The McMillan Company, N. Y.
Meier, G. and Muller, G., 1965, Isotopenpraxis, Isotope analysis of nitrogen by emission spectroscopy with photoelectric recording,1, 53–62.
Roncucci, R., 1969, Biochimica Applicata, Applicazione delle tecniche di combustione alia scintillazione in fase liquida,16, 71–103.
Roncucci, R., Lambelin, G., Simon, M.-J. and Soudyn, W., 1968, Anal. Biochem., Simultaneous liquid scintillation determination of tritium and sulfur-35 in biological low-level samples using the oxygen flask method,26, 118–136.
Knapp, D. R., Gaffney, T. E., McMahon, R. E. and Kiplinger, G., 1972, J. Pharmacol. Exp. Ther., Studies on human urinary and biliary metabolites of nortriptyline with stable isotope labelling,180, 784–790.
Cornides, I., 1970, «Proceedings of the Vlth International Symposium on Microtechniques», Graz, Osterreich.
Klein, P. D., Haumann, J. R. and Eisler, W. J., 1970, Anal. Chem., Gas chromatograph-mass spectrometer accelerating voltage alternator system for the measurement of stable isotope ratios in organic molecules,44, 490–493.
Draffan, G. H., Clare, R. A., Williams, F. M., Emons, E. and Jackson, J. L., 1974, in: «Mass spectrometry in biochemistry and medicine», Ed. A. Frigerio and N. Castagnoli, Raven Press, N. Y.
Carrington, R., Frigerio, A. and Roncucci, R., 1976,in: «Methods in drug metabolism research», Ed. E. R. Garret and J. L. Hirtz (to be published).
Hammar, C. G. and Hessling, R., 1971, Anal. Chem., Novel peak matching technique by means of a new and combined multiple ion detector-peak matcher device. Elemental analysis of compounds in submicrogram quantities without prior isolation,43, 298–306.
Finn, C. B. and Sadee, W., 1975, Cancer Chemother., Determination of 5-fluorouracil (SNC-19893) plasma levels in rats and man by isotope dilution-mass fragmentography,1, 279–286.
Roncucci, R., Simon, M.-J., Lambelin, G. and Debast, K., 1974, in: « Mass spectrometry in Biochemistry and Medicine», Ed. A. Frigerio and N. Castagnoli, Raven Press, N.Y.
Roncucci, R., Simon, M.-J., Gillet, C, Lambelin, G. and Kaisin, M., 1972, «Proceedings of the International Symposium on gas chromatography mass spectrometry», Isle of Elba, Italy, Ed. A. Frigerio, Tamburini Editore, Milano.
Roncucci, R., Simon, M.-J., Lambelin, G. and Debast, K., 1976, in : «Proceedings of the Second International Symposium on Mass Spectrometry in Biochemistry and Medicine», Milano, 24–26 June, 1974, Ed. A. Frigerio and N. Castagnoli, Spectrum Publications (in the press).
Hammar, C. G. and Holmstedt, B. O., 1968, Anal. Biochem., Mass fragmentography. Identification of chlorpromazine and its metabolites in human blood by a new method,25, 532–548.
McMahon, R. E., Sullivan, H. R., Due, S. L. and Marshall, F. J., 1973, Life Sci., The metabolite pattern ofd-propoxyphene in man. The use of heavy isotopes in drug disposition studies,12, 463–473.
Knapp, D. R., Gaffney, T. E. and McMahon, R. E., 1972, Biochem. Pharmacol., Use of stable isotope mixtures as a labelling technique in drug metabolism studies,21, 425–429.
Garland, W. A., Trager, W. F. and Nelson, S. D., 1974, Biomed. Mass Spectrom., Direct (non-chromatographic) quantification of drugs and their metabolites from human plasma utilizing chemical ionization mass spectrometry and stable isotope labelling: quinidine and lidocaine,1, 124–129.
Zimmer, A., Prox, A., Pelzer, H. and Hankwitz, R., 1973, Biochem. Pharmacol., Simultaneous labelling with stable and radioactive isotopes in drug metabolism studies,22, 2213–2222.
Roncucci, R., Simon, M.-J., Debast, K., Vandriessche, R., Gillet, C. and Lambelin, G., 1976,in: «Proceedings of the Third International Symposium of Mass Spectrometry in Biochemistry and Medicine». Alghero, Italy, June 16–18, 1975, Ed. A. Frigerio (in the press).
Horning, M. G., Stillwell, W. G., Nowlin, J., Lertratanangkoon, K., Carroll, D., Dzidic, I., Stillwell, R. N. and Horning, E. C, 1974, J. Chromatogr., Use of stable isotope in gas chromatography-mass spectrometric studies of drug metabolism,91, 413–423.
Fales, H. M., 1972, Pharmacology, Newer physicochemical methods useful in bioavailability studies,8, 142–147.
Hamming, M. C. and Foster, N. G., 1972, «Interpretation of mass spectra of organic compounds», Academic Press, N. Y.
McLafferty, F. M., 1967, «Interpretation of mass spectra, an introduction», Benjamin, N. Y.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Roncucci, R., Simon, M.J., Jacques, G. et al. Stable isotopes in drug metabolism and pharmacokinetics. European Journal of Drug Metabolism and Pharmacokinetics 1, 9–20 (1976). https://doi.org/10.1007/BF03192274
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03192274